285 related articles for article (PubMed ID: 22611307)
1. Pathogenesis of NSAID-induced gastric damage: importance of cyclooxygenase inhibition and gastric hypermotility.
Takeuchi K
World J Gastroenterol; 2012 May; 18(18):2147-60. PubMed ID: 22611307
[TBL] [Abstract][Full Text] [Related]
2. COX inhibition and NSAID-induced gastric damage--roles in various pathogenic events.
Takeuchi K; Tanaka A; Hayashi Y; Yokota A
Curr Top Med Chem; 2005; 5(5):475-86. PubMed ID: 15974942
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of COX-2 by inhibition of COX-1 in the rat: a key to NSAID-induced gastric injury.
Tanaka A; Araki H; Hase S; Komoike Y; Takeuchi K
Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():90-101. PubMed ID: 11966529
[TBL] [Abstract][Full Text] [Related]
4. Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility.
Takeuchi K; Tanaka A; Hayashi Y; Kubo Y
Dig Dis Sci; 2004 Feb; 49(2):180-7. PubMed ID: 15104355
[TBL] [Abstract][Full Text] [Related]
5. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs.
Tanaka A; Araki H; Komoike Y; Hase S; Takeuchi K
J Physiol Paris; 2001; 95(1-6):21-7. PubMed ID: 11595414
[TBL] [Abstract][Full Text] [Related]
7. Both selective COX-1 and COX-2 inhibitors aggravate gastric damage induced in rats by 2-deoxy-D-glucose. relation to gastric hypermotility and COX-2 expression.
Takeuchi K; Miyazawa T; Matsumoto M; Hayashi Y
Digestion; 2003; 68(2-3):71-9. PubMed ID: 14581763
[TBL] [Abstract][Full Text] [Related]
8. Gastric acid is the key modulator in the pathogenesis of non-steroidal anti-inflammatory drug-induced ulceration in rats.
Zinkievich JM; George S; Jha S; Nandi J; Levine RA
Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):654-61. PubMed ID: 20082628
[TBL] [Abstract][Full Text] [Related]
9. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
[TBL] [Abstract][Full Text] [Related]
10. Development of intestinal, but not gastric damage caused by a low dose of indomethacin in the presence of rofecoxib.
Yokota A; Taniguchi M; Tanaka A; Takeuchi K
Inflammopharmacology; 2005; 13(1-3):209-16. PubMed ID: 16259740
[TBL] [Abstract][Full Text] [Related]
11. Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage.
Takeuchi K; Tanaka A; Kato S; Amagase K; Satoh H
Clin Chim Acta; 2010 Apr; 411(7-8):459-66. PubMed ID: 20074562
[TBL] [Abstract][Full Text] [Related]
12. Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage.
Takeuchi K; Tanaka A; Ohno R; Yokota A
J Physiol Pharmacol; 2003 Dec; 54 Suppl 4():165-82. PubMed ID: 15075458
[TBL] [Abstract][Full Text] [Related]
13. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
Kato S; Ogawa Y; Kanatsu K; Okayama M; Watanabe T; Arakawa T; Takeuchi K
J Pharmacol Exp Ther; 2002 Nov; 303(2):503-9. PubMed ID: 12388629
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing.
Colucci R; Antonioli L; Bernardini N; Ippolito C; Segnani C; Awwad O; Tuccori M; Blandizzi C; Scarpignato C; Fornai M
J Pharmacol Exp Ther; 2012 Jul; 342(1):140-9. PubMed ID: 22495067
[TBL] [Abstract][Full Text] [Related]
15. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge.
Gretzer B; Maricic N; Respondek M; Schuligoi R; Peskar BM
Br J Pharmacol; 2001 Apr; 132(7):1565-73. PubMed ID: 11264251
[TBL] [Abstract][Full Text] [Related]
16. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.
Takeeda M; Hayashi Y; Yamato M; Murakami M; Takeuchi K
J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):193-205. PubMed ID: 15082878
[TBL] [Abstract][Full Text] [Related]
17. Functional mechanism underlying cyclooxygenase-2 expression in rat small intestine following administration of indomethacin: relation to intestinal hypermotility.
Tanaka A; Matsumoto M; Hayashi Y; Takeuchi K
J Gastroenterol Hepatol; 2005 Jan; 20(1):38-45. PubMed ID: 15610444
[TBL] [Abstract][Full Text] [Related]
18. Gastric motility and mucosal ulcerogenic responses induced by prokinetic drugs in rats under prostaglandin-deficient conditions.
Takeuchi K; Kato S; Hirata T; Nishiwaki H
Dig Dis Sci; 1997 Feb; 42(2):251-8. PubMed ID: 9052502
[TBL] [Abstract][Full Text] [Related]
19. Interaction between NSAIDs and steroid in rat stomach: safety of nimesulide as a preferential COX-2 inhibitor in the stomach.
Kataoka H; Horie Y; Koyama R; Nakatsugi S; Furukawa M
Dig Dis Sci; 2000 Jul; 45(7):1366-75. PubMed ID: 10961716
[TBL] [Abstract][Full Text] [Related]
20. Permissive role of neutrophils in pathogenesis of indomethacin-induced gastric lesions in rats.
Suzuki K; Araki H; Komoike Y; Takeuchi K
Med Sci Monit; 2000; 6(5):908-14. PubMed ID: 11208431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
